13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 65 holding rows worth $2,183,557,000.
- Accession
- 0001856083-22-000012
- Filer
- CIK 1856083
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 65 entries on the cover page, a total value of $2,183,557,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,183,559,000 with VALUE read as thousands by filing date, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IVERIC BIO INC | 46583P102 | COM | 7,000,000 | $125,580,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 861,000 | $114,763,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,000,000 | $103,260,000 | thousands by filing date | call |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 4,000,000 | $98,560,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 1,293,761 | $98,300,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,462,800 | $90,533,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 800,000 | $82,608,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 2,369,210 | $67,594,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 2,900,000 | $67,454,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 738,863 | $62,633,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 3,000,000 | $58,980,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 9,860,246 | $55,020,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 26,325,000 | $53,966,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,000,000 | $47,640,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,186,083 | $43,522,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 5,677,372 | $42,694,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,184,200 | $40,439,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,970,290 | $40,411,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 3,127,667 | $37,939,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 3,778,818 | $37,902,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 5,636,587 | $37,765,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,814,844 | $37,043,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 8,548,387 | $36,074,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,000,000 | $35,880,000 | thousands by filing date | call |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,374,394 | $33,204,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,311,113 | $29,382,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,399,744 | $29,241,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,829,094 | $28,913,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 4,518,575 | $27,654,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 790,926 | $26,931,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,053,621 | $26,759,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 775,000 | $26,621,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,824,000 | $26,466,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 3,196,642 | $25,701,000 | thousands by filing date | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 1,268,220 | $24,058,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 326,600 | $22,241,000 | thousands by filing date | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 2,363,188 | $21,505,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 1,110,624 | $21,502,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 9,325,540 | $20,889,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,053,000 | $20,681,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 1,000,000 | $20,280,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,951,580 | $19,584,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 966,573 | $19,283,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 14,858,000 | $17,681,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 460,861 | $17,061,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 300,000 | $16,788,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 2,636,000 | $15,262,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 1,177,680 | $12,342,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 825,508 | $11,739,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 4,259,653 | $9,968,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 248,500 | $9,349,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 360,000 | $9,184,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 924,641 | $9,145,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 3,250,000 | $8,710,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 772,700 | $8,098,000 | thousands by filing date | call |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 316,800 | $7,961,000 | thousands by filing date | put |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 5,359,000 | $7,556,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 900,711 | $7,287,000 | thousands by filing date | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 5,035,998 | $6,748,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 499,400 | $5,803,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 3,000,000 | $4,920,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 117,200 | $4,339,000 | thousands by filing date | call |
| SCHRODINGER INC COM | 80810D103 | Stock | 170,000 | $4,247,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 1,439,062 | $1,799,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 45,500 | $117,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-22-000012 | this filing | 2022-11-14 | acceptance time not in the bulk data set |